Population pharmacokinetics of pentobarbital in neonates, infants, and children after open heart surgery.
Population pharmacokinetics of pentobarbital in neonates, infants, and children after open heart surgery.
复制标题
新生儿、婴儿和儿童心脏直视手术后戊巴比妥的群体药代动力学。
DOI:
10.1016/j.jpeds.2011.04.021
复制
发表时间:
2011
期刊:
影响因子:
--
通讯作者:
Gastonguay,MarcR
中科院分区:
文献类型:
--
作者:
Zuppa,AthenaF;Nicolson,SusanC;Barrett,JeffreyS;Gastonguay,MarcR
OBJECTIVESTo determine the pharmacokinetics of pentobarbital in neonates, infants, and young children with congenital heart disease after open-heart surgery.STUDY DESIGNThirty-five subjects (3.0 days-4.4 years) after open-heart surgery who received pentobarbital as standard of care were enrolled. Serial pharmacokinetic blood samples were obtained. A population-based, nonlinear mixed-effects modeling approach was used to characterize pentobarbital pharmacokinetics.RESULTSA two-compartment model with weight as a co-variate allometrically expressed on clearance (CL), inter-compartmental clearance, central (V1) and peripheral volume of distributions, bypass grafting time as a co-variate on CL and V1, and age and ventricular physiology as co-variates on CL best described the pharmacokinetics. A typical infant (two-ventricle physiology, 6.9 kg, 5.2 months, and bypass grafting time of 60 minutes) had a CL of 0.12 L/hr/kg, V1 of 0.45 L/kg, and peripheral volume of distributions of 0.98 L/kg. The bypass grafting effect was poorly estimated. For subjects <12 months age, an age effect on CL remained after accounting for weight and was precisely estimated.CONCLUSIONSPentobarbital pharmacokinetics is influenced by age and weight. Subjects with single-ventricle physiology demonstrated a 15% decrease in clearance when compared with subjects with two-ventricle physiology.